International Biotechnology Trust PLC Alkermes Plc. Transaction History

International Biotechnology Trust PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$22.0 - $31.87 $13 Million - $18.9 Million	591,481 Added 38938.84%	593,000 $13.2 Million
Q2 2022 Aug 16, 2022	BUY	$26.4 - $30.54 $40,101 - $46,390	1,519 New	1,519 $51 Million
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $1.05 Million - $1.45 Million	-45,000 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$18.78 - $25.15 $845,100 - $1.13 Million	45,000 New	45,000 $1.1 Million
Q2 2020 Jul 14, 2020	SELL	$13.31 - $19.41 $692,120 - $1.01 Million	-52,000 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$13.06 - $21.24 $679,120 - $1.1 Million	52,000 New	52,000 $749,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $1.37 Million - $1.7 Million	-70,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $3.5 Million - $6.08 Million	-163,000 Reduced 69.96%	70,000 $1.58 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $36.49 $6.62 Million - $8.5 Million	233,000 New	233,000 $8.5 Million

364

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.61B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.